COOPERATIVES WORKING IN THE PHARMACY SECTOR FRANCE Rome March 31st 2009
<ul><li>1. Distribution & Pharmacies suffer from market pressure </li></ul><ul><li>•  Price structure on reimbursed medici...
<ul><li>2. Direct sales to pharmacy by manufacturers on reimbursed medicines </li></ul><ul><li>2001 = 8,3% </li></ul><ul><...
<ul><li>3. Generic market </li></ul><ul><li>2008 = 10% value and 20% volume </li></ul><ul><li>57% of the distribution is d...
4. New risks emerged in France Opening of the capital of pharmacies DTP model (as in the UK) Double pricing Quota system =...
Strategies of cooperatives in France become clearer: - consolidation of wholesale activities at European level (Millenium)...
Groupe WELCOOP (ex Cerp Lorraine Group)  proposes to the 22,600 pharmacies of France to  become owner of their suppliers. ...
This new economic model is based on 3 major grounds: 1. Computing and Management with Pharmagest Interactive, leader in Fr...
This new economic model adds a two-way value for the pharmacists: - increasing the margins with the right to get cooperati...
Future priorities and strategies for French cooperatives : Find the model of tomorrow to allow the pharmacists to remain c...
Thank you  for your attention !
Upcoming SlideShare
Loading in …5
×

France Groupe Welcoop

1,679 views
1,578 views

Published on

Published in: Health & Medicine, Travel
0 Comments
1 Like
Statistics
Notes
  • Be the first to comment

No Downloads
Views
Total views
1,679
On SlideShare
0
From Embeds
0
Number of Embeds
1
Actions
Shares
0
Downloads
21
Comments
0
Likes
1
Embeds 0
No embeds

No notes for slide

France Groupe Welcoop

  1. 1. COOPERATIVES WORKING IN THE PHARMACY SECTOR FRANCE Rome March 31st 2009
  2. 2. <ul><li>1. Distribution & Pharmacies suffer from market pressure </li></ul><ul><li>• Price structure on reimbursed medicines for France </li></ul><ul><li>1999 2007 </li></ul><ul><li>State 5,9% 6.6% </li></ul><ul><li>Manufacturer 64.2% 67.6% </li></ul><ul><li>Wholesale 3.8% 2.5% </li></ul><ul><li>Pharmacies 26.1% 23.3% </li></ul><ul><li>Wholesalers are suffering most </li></ul>KEY FIGURES & FACT
  3. 3. <ul><li>2. Direct sales to pharmacy by manufacturers on reimbursed medicines </li></ul><ul><li>2001 = 8,3% </li></ul><ul><li>2006 = 15% </li></ul><ul><li>Estimated 2012 = 19,5% </li></ul><ul><li>France is N°1 for direct sales in Europe </li></ul>KEY FIGURES & FACT
  4. 4. <ul><li>3. Generic market </li></ul><ul><li>2008 = 10% value and 20% volume </li></ul><ul><li>57% of the distribution is done by direct sales, </li></ul><ul><li>not by full line wholesalers </li></ul>Turnover in Millions € KEY FIGURES & FACT
  5. 5. 4. New risks emerged in France Opening of the capital of pharmacies DTP model (as in the UK) Double pricing Quota system => A new economic model is being modelled towards the development of services to pharmacies KEY FIGURES & FACT
  6. 6. Strategies of cooperatives in France become clearer: - consolidation of wholesale activities at European level (Millenium) - wholesale competition at national level in areas where historically cooperatives were lonely (Cerp Rouen, Cerp Rhin Rhône Méditerranée) - connections with Group of pharmacies (CERPenthès) - disengagement of the historic wholesale business activity (Cerp Lorraine sold to Phoenix Pharma) - introduction of a new economic model (Groupe Welcoop)
  7. 7. Groupe WELCOOP (ex Cerp Lorraine Group) proposes to the 22,600 pharmacies of France to become owner of their suppliers. WELCOOP : THE NEW ECONOMIC MODEL
  8. 8. This new economic model is based on 3 major grounds: 1. Computing and Management with Pharmagest Interactive, leader in France with 43% market share equipping 9.800 pharmacies in France with a complete back-office solution 2. Advice and Organization with Profidia (merchandising, pricing structure, geomarketing…) 3. Products Offer with Generics (Cristers), Medical Equipment (D,Médica) and Parallel Imports (Pharma Lab)
  9. 9. This new economic model adds a two-way value for the pharmacists: - increasing the margins with the right to get cooperative dividends based on a percentage on all purchases done with the Products Offer (20% for Cristers, 4% for D,Médica, 5% for Pharma Lab), - accessing the capital of the Group by opening the capital of the holding Welcoop Pharma
  10. 10. Future priorities and strategies for French cooperatives : Find the model of tomorrow to allow the pharmacists to remain competitive, liberal and independent.
  11. 11. Thank you for your attention !

×